Publication | Open Access

An implantable drug delivery system (IDDS) for refractory cancer pain provides sustained pain control, less drug-related toxicity, and possibly better survival compared with comprehensive medical management (CMM)

Pain TherapyPain ResearchHealth SciencesRefractory Cancer PainPain MedicineMedicineSustained Pain ControlCancer PainDrug Delivery SystemsPain ManagementBiomedical EngineeringOncologyRadiation OncologyComprehensive Medical ManagementPain Treatment